BioEclipse Therapeutics
PrivateLast Round
Grant
Apr 26, 2022
Total Funding Raised
$17.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BioEclipse Therapeutics is a biotechnology company that develops immuno-oncology therapeutics designed to kill tumor cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioEclipse Therapeutics Comparables
Compare BioEclipse Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Calidi Biotherapeutics | 78% | |
| Genelux Corporation | 77% | |
| EpicentRx | 76% | |
BioEclipse Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 26, 2022 | ||||
| Crowdfunding | Jan 19, 2022 | ||||
| Series A | Jun 24, 2019 | ||||
| Seed | Jul 21, 2016 |
Key People
Founding team and executive leadership
BioEclipse Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Revelis Capital Group | Series A |
| Plum Alley Investments | Series A |
| Foothill Ventures | Series A |
| California Institute for Regenerative Medicine | Grant |
| TSV Capital | Series A |
| DEFTA Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 152% MoM.
- Apr 16, 2026
Monthly visitors increased 61% MoM.
BioEclipse Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioEclipse Therapeutics's valuation, stock price, and market status.